<?xml version="1.0" encoding="UTF-8"?><doi_batch version="4.3.7" xmlns="http://www.crossref.org/schema/4.3.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd">
		<head>
		<doi_batch_id>eamdacademy.org-B5Yi-1795051259-p948328217</doi_batch_id>
		<timestamp>1795051259</timestamp>
		<depositor>
			<depositor_name>Eurasian Academy of Medicine and Dentistry</depositor_name>
			<email_address>info@eamdacademy.org</email_address>
		</depositor>
		<registrant>Eurasian Academy of Medicine and Dentistry</registrant>
	</head>
	<body>
		<journal>
			<journal_metadata>
				<full_title>Journal of Applied Pharmaceutical Technologies and Systems</full_title>
				<abbrev_title>J Appl Pharm Technol Syst</abbrev_title>
				<issn>3149-9589</issn>
			</journal_metadata>
			<journal_issue>
				<publication_date>
					<year>2025</year>
				</publication_date>
				<journal_volume>
					<volume>4</volume>
				</journal_volume>
				<issue>1</issue>
			</journal_issue>
			<journal_article publication_type="full_text">
				<titles>
					<title>Potential Effects of Sildenafil Citrate on Hematological and Biochemical Profiles in Hyperglycemic Rats</title>
				</titles>
								<contributors>
          					<person_name sequence="first" contributor_role="author">
            <given_name>Nguyen Thi</given_name>
            <surname>Lan</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Tran Minh</given_name>
            <surname>Duc</surname>
					</person_name>
          				</contributors>
								<publication_date>
					<year>2025</year>
				</publication_date>
				<doi_data>
					<doi>10.68159/p948328217</doi>
					<resource>https://eamdacademy.org/pub/journal/3/article/p948328217</resource>
				</doi_data>
				<citation_list>
          					<citation key="rk-10.68159/p948328217-3f7c6b34-088e-4c93-a653-eaeb6e268775">
					  <unstructured_citation>WHO, Global Report on Diabetes. 1. Diabetes Mellitus—Epidemiology, World Health Organization, Geneva, Switzerland, 2016.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-049e83a2-7a28-413e-a748-c97920a815ac">
					  <unstructured_citation>Hile C, Veves A. Diabetic neuropathy and microcirculation. Curr Diab Rep. 2003;3(6):446-51.</unstructured_citation>
						 <doi>10.1007/s11892-003-0006-0</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-56a3e72b-029a-4a8e-82ed-d9cca2917e26">
					  <unstructured_citation>Adinoyi S. Sildenafil citrate in healthy and diseased hearts. J Cardiol Cardiovasc Med. 2021;6(1):33-9.</unstructured_citation>
						 <doi>10.29328/journal.jccm.1001115</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-2a68ceb9-2e24-46ec-a1a1-ce9fe30a1891">
					  <unstructured_citation>Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH. Chronic treatment with sildenafil improves energy balance and insulin action in high-fat-fed conscious mice. Diabetes. 2007;56(4):1025-33.</unstructured_citation>
						 <doi>10.2337/db06-0883</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-3d21d94c-44ac-4dad-8ecc-dcb186ea32a7">
					  <unstructured_citation>Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018;17(1):121.</unstructured_citation>
						 <doi>10.1186/s12933-018-0763-3</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-4e343987-7567-4fe6-ae9a-b223471a1d7b">
					  <unstructured_citation>Ghibli S, Samsonov AP, Gheibi S, Vazquez AB, Kashfi K. Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: implications in diabetes. Biochem Pharmacol. 2020;176:113819.</unstructured_citation>
						 <doi>10.1016/j.bcp.2020.113819</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-a62e452d-1b87-440c-8659-d5ff7b8e3368">
					  <unstructured_citation>Ramirez CE, Nian H, Yu C, Gamboa JL, Luther JM, Brown NJ, et al. Treatment with sildenafil improves insulin sensitivity in prediabetes: a randomized, controlled trial. J Clin Endocrinol Metab. 2015;100(12):4533-40.</unstructured_citation>
						 <doi>10.1210/jc.2015-3415</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-95059cd7-eb3d-4d58-83f4-cf0dd4e6e0e9">
					  <unstructured_citation>Zimmermann LM, Baptista MS, Tardivo JP, Pinhal MA. Type II Diabetes patients under sildenafil citrate: case series showing benefits and a side effect. Case Rep Med. 2020; 9;2020:4065452.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-e5610a36-9ee1-4b56-a019-7bd35fa17e18">
					  <unstructured_citation>Mendes TC, Silva GR, Shirabayashi JB, Geronimo E, Melo Germano R, Wietzikoski E, et al. Induction of diabetes in Wistar rats: is the streptozotocin model feasible at any age? Braz J Dev. 2020;6(6):40153-64.</unstructured_citation>
						 <doi>10.34117/bjdv6n6-523</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-426572c6-d23c-47dd-a583-c26ddfe1b67a">
					  <unstructured_citation>Adebayo AA, Oboh G, Ademosun AO. Almond-supplemented diet improves sexual functions beyond Phosphodiesterase-5 inhibition in diabetic male rats. Heliyon. 2019;5(12):e03035.</unstructured_citation>
						 <doi>10.1016/j.heliyon.2019.e03035</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-af950b0b-9d49-4898-9494-eea52db7cabd">
					  <unstructured_citation>Meky NH, Abd El-Ghaffar EA, Ibrahim EM, Hegazy HG, Elabassy MS. The potential effect of sildenafil citrate on some biochemical and hematological parameters in alloxan-induced Type I diabetes in male rats. J Exp Biol. 2017;13(1):115-24.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-ed5ba9fd-659f-426e-bb49-afcfb61923bf">
					  <unstructured_citation>Elsayed ME, Eid N, Kamel AS. Beneficial effects of certain phosphodiesterase inhibitors on diabetes mellitus in rats. Bulletin of Faculty of Pharmacy, Cairo University. 2014;52:(2)179-89.</unstructured_citation>
						 <doi>10.1016/j.bfopcu.2014.06.001</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-345184e9-c015-4981-9116-7e597871a47b">
					  <unstructured_citation>Taha AM, Hardy HH, Ghareip A, Nour el-deen AE, Ashour YM. Effect of sildenafil citrate on prediabetic and diabetic albino rats treated with metformin. Int J Cur Res Physiol Pharmacol. 2021;5(1):4-13.</unstructured_citation>
						 <doi>10.31878/ijcrpp.2021.51.02</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-6be19bd6-6637-4a61-b5c2-cb4ae325da6b">
					  <unstructured_citation>Antinozzi C, Sgrò P, Di Luigi L. Advantages of Phosphodiesterase Type 5 Inhibitors in the management of glucose metabolism disorders: a clinical and translational issue. Int J Endocrinol. 2020;2020:7078108.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-7ff42295-585b-4083-a8d5-331ae9607912">
					  <unstructured_citation>Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med. 2012;2012:918267.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-82e4e765-b4dc-48c0-a7a8-224729370bab">
					  <unstructured_citation>Ugwoke CK, Cvetko E, Umek N. Skeletal muscle microvascular dysfunction in obesity-related insulin resistance: pathophysiological mechanisms and therapeutic perspectives. Int J Mol Sci. 2022;23(2):847.</unstructured_citation>
						 <doi>10.3390/ijms2302084</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-b3cdd64a-f649-41ce-9f1a-7d42fd06873b">
					  <unstructured_citation>Pauls MM, Moynihan B, Barrick TR, Kruuse C, Madigan JB, Hainsworth AH, et al. The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: a systematic review. J Cereb Blood Flow Metab. 2018;38(2):189-203.</unstructured_citation>
						 <doi>10.1177/0271678X17747177</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-09e4f7ad-7ed8-47f1-8bd3-b754193d5c3e">
					  <unstructured_citation>Milani E, Nikfar S, Khorasani R, Zamani MJ, Abdollahi M. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp Biochem Physiol Toxicol Pharmacol. 2005;140(2):251-5.</unstructured_citation>
						 <doi>10.1016/j.cca.2005.02.010</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-f8d42a59-def1-429e-a7e0-5d2a89805d41">
					  <unstructured_citation>Rhee SY, Kim YS. The role of advanced glycation end products in diabetic vascular complications. Diabet Metabol J. 2018;42(3):188-95.</unstructured_citation>
						 <doi>10.4093/dmj.2017.0105</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-f5884e00-c630-4557-8d1d-ffc899e18014">
					  <unstructured_citation>Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137-88.</unstructured_citation>
						 <doi>10.1152/physrev.00045.2011</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-5e019091-cfc8-43cd-8543-8d67e9a7a6e6">
					  <unstructured_citation>Han HS, Kang G, Kim JS, Choi BH, Koo SH. Regulation of glucose metabolism from a liver-centric perspective. Exp Mol Med. 2016;48(3):e218.</unstructured_citation>
						 <doi>10.1038/emm.2015.122</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-0d092f42-28a5-4ab6-b271-9a04284891bd">
					  <unstructured_citation>Li X, Wang X, Gao P. Diabetes mellitus and risk of hepatocellular carcinoma. Biomed Res Int. 2017;2017:5202684.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-e706340e-f118-48b3-915d-0754115a5894">
					  <unstructured_citation>Ramesh B, Viswanathan P, Pugalendi KV. Protective effect of Umbelliferone on membranous fatty acid composition in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2007;566(1-3):231-9.</unstructured_citation>
						 <doi>10.1016/j.ejphar.2007.03.045</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-a06aa932-8f8b-4eee-92a5-c8a09bb06426">
					  <unstructured_citation>Halverscheid L, Deibert P, Schmidt R, Blum HE, Dunkern T, Pannen BH, et al. Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver. BMC Gastroenterol. 2009;9(1):69.</unstructured_citation>
						 <doi>10.1186/1471-230X-9-69</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-d34269ea-4e55-4a97-9e29-836e65b53bb1">
					  <unstructured_citation>Alashry SE, Gaballah MA, Malek HA, Abd Elsalam AI. Effect of sildenafil on non-alcoholic fatty liver. Int J Pharmacol. 2015;11(7):814-20.</unstructured_citation>
						 <doi>10.3923/ijp.2015.814.820</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-07298a5e-b563-45a8-bb65-ccf8bd4c5eec">
					  <unstructured_citation>Hameed N, Farooq K. Protective role of sildenafil citrate in isoniazid-rifampicin induced histomorphological changes in the liver of albino mice. Anatomy. 2021;15(1):52-8.</unstructured_citation>
						 <doi>10.2399/ana.21.829636</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-e4ba4fe3-c3d8-4599-89cf-c1c6705da971">
					  <unstructured_citation>Nogueira Júnior FC, Coelho DA, Almeida MM, Silva TC, Ferreira EC, Macedo UB, et al. Effect of tamoxifen in lipids of diabetic rats induced by streptozotocin. Acta Cir Bras. 2005;20(1):114-20.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-909a5eda-c0e7-46eb-81b6-a473ef2cc185">
					  <unstructured_citation>Khan HA, Ola Ms. Markers of blood coagulation, lipid profile, renal function test and serum electrolytes in streptozotocin-induced diabetic rats. Biomed Res. 2012;23(3):421-4.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-b7931922-0d6f-4c8d-864e-bae149efaa81">
					  <unstructured_citation>Stampe C, Atkins RC, Tesch GH, Kapoun AM, Hill PA, Schreiner GF, et al. Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol. 2003;14(2):338-51.</unstructured_citation>
						 <doi>10.1097/01.asn.0000048715.12315.fd</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-80b6d1e8-e2e2-4730-a98e-73b31fa9c522">
					  <unstructured_citation>Pofi R, Fiore D, De Gaetano R, Panio G, Gianfrilli D, Pozza C, et al. Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7. Sci Rep. 2017;7(1):44584.</unstructured_citation>
						 <doi>10.1038/srep44584</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-75fb909f-42b1-4b5c-9ec4-85dbd00b25f9">
					  <unstructured_citation>Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Espinoza F, Pons H, et al. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int. 2005;68(5):2131-42.</unstructured_citation>
						 <doi>10.1111/j.1523-1755.2005.00669.x</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-a0edb818-34b9-499b-b436-f67ab23109a4">
					  <unstructured_citation>Rizk AA, Shawky YM, Motawie AG. Can sildenafil citrate ameliorate cisplatin-induced nephrotoxicity? Crosstalk between the possible mechanisms. Eur J Anat. 2019;23(2):113-9.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/p948328217-a9fd59c6-80e2-4a04-a4e7-054143c0ad50">
					  <unstructured_citation>Zhao Y, Zhang J, Zhang J, Wu J. Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values. Malaga G, ed. PLoS One. 2011;6(1):e16470.</unstructured_citation>
						 <doi>10.1371/journal.pone.0016470</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-0da0f576-3ee1-4594-910b-eb8e228ef7d8">
					  <unstructured_citation>Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood. 2004;104(12):3631-4.</unstructured_citation>
						 <doi>10.1182/blood-2004-03-1042</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-cc59db94-0f61-44b5-957b-4cc500985a84">
					  <unstructured_citation>Luzak B, Moncler M, Kosmalski M, Mnich E, Stanczyk L, Przygodzki T, et al. Fibrinogen glycation and presence of glucose impair fibrin polymerization-an in vitro study of isolated fibrinogen and plasma from patients with diabetes mellitus. Biomolecules. 2020;10(6):877.</unstructured_citation>
						 <doi>10.3390/biom10060877</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-19c4c515-d4bd-42f3-bf42-276d0e292b06">
					  <unstructured_citation>Karim F, Akhter QS, Jahan S, Khanom A, Haque S, Yeasmin T, et al. Coagulation impairment in Type 2 diabetes mellitus. J Bangladesh Soc Physiol. 2015;10(1):26-9.</unstructured_citation>
						 <doi>10.3329/jbsp.v10i1.24614</doi> 					</citation>
          					<citation key="rk-10.68159/p948328217-eb3d46e7-eda8-44fb-8b8e-c24e17c0da4e">
					  <unstructured_citation>Asrat D, Tesfaye G, Gedefaw L, Addisu W, Yemane T. Hemostatic abnormality and associated factors in diabetic patients at jimma university specialized hospital, jimma, southwest ethiopia: a comparative cross-sectional study. Ethiop J Health Sci. 2019;29(2):251-8.</unstructured_citation>
						 <doi>10.4314/ejhs.v29i2.12</doi> 					</citation>
          				</citation_list>
			</journal_article>
		</journal>
	</body>
</doi_batch>
